Published on Mon, Jul 23, 2007 at 13:48 | Source : Moneycontrol.com
Updated at Mon, Jul 23, 2007 at 19:34
Like this story, share it with millions of investors on M3
0
Like this story, share it with millions of investors on M3
Sun Pharma Q1 net seen up 34% at Rs 218.76cr
Sun Pharma is to announce its Q1FY08 numbers. According to CNBC-TV18 estimates, the company is expected to post growth of 34% in its first quarter net profit at Rs 218.76 crore as against Rs 176.73 crore in corresponding quarter of previous year.
Sun Pharma is to announce its Q1FY08 numbers. According to CNBC-TV18 estimates, the company is expected to post growth of 34% in its first quarter net profit at Rs 218.76 crore as against Rs 176.73 crore in corresponding quarter of previous year.
Net sales is seen going up 28% to Rs 601.78 crore from Rs 511.64 crore. Operating profit is likely to go up at Rs 214.7 crore versus Rs 181.01 crore and operating margin is also seen inching up to 36 % versus 35%.
Factors to watch for
Expect good growth in both domestic & international markets
Growth in sales from its US subsidiary Caraco
Growth from introduction of new products in non - US markets
May post high other income because of forex gain through FCCB
Outlook
To raise upto Rs 3500 crore through GDRs, FCCB, Bonds, Debentures etc
Reduction in R& D cost on account of demreger of R& D division
Strong opposition of Taro acquisition by Taro investors
